1. Clin Infect Dis. 2021 Sep 15;73(6):e1345-e1347. doi: 10.1093/cid/ciab374.

Disease Severity and Durability of the Severe Acute Respiratory Syndrome 
Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the 
Second Year of the Pandemic.

Pirofski LA(1).

Author information:
(1)Division of Infectious Diseases, Albert Einstein College of Medicine and 
Montefiore Medical Center, Bronx, New York, USA.

Comment on
    Clin Infect Dis. 2021 Sep 15;73(6):e1337-e1344. doi: 10.1093/cid/ciab308.

DOI: 10.1093/cid/ciab374
PMCID: PMC8135546
PMID: 33905478 [Indexed for MEDLINE]